Vanguard Group’s Strata Critical Medical, Inc. Class A Common Stock SRTA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $13.3M | Buy |
3,299,015
+44,140
| +1% | +$178K | ﹤0.01% | 2753 |
|
|
2025
Q1 | $8.89M | Buy |
3,254,875
+81,962
| +3% | +$224K | ﹤0.01% | 2908 |
|
|
2024
Q4 | $13.5M | Buy |
3,172,913
+183,941
| +6% | +$782K | ﹤0.01% | 2786 |
|
|
2024
Q3 | $8.79M | Buy |
2,988,972
+60,874
| +2% | +$179K | ﹤0.01% | 3022 |
|
|
2024
Q2 | $10.2M | Sell |
2,928,098
-39,402
| -1% | -$137K | ﹤0.01% | 2905 |
|
|
2024
Q1 | $8.46M | Buy |
2,967,500
+28,622
| +1% | +$81.6K | ﹤0.01% | 3053 |
|
|
2023
Q4 | $10.4M | Buy |
2,938,878
+120,890
| +4% | +$427K | ﹤0.01% | 2926 |
|
|
2023
Q3 | $7.3M | Buy |
2,817,988
+22,090
| +0.8% | +$57.2K | ﹤0.01% | 3076 |
|
|
2023
Q2 | $11M | Sell |
2,795,898
-15,086
| -0.5% | -$59.4K | ﹤0.01% | 2891 |
|
|
2023
Q1 | $9.5M | Buy |
2,810,984
+5,346
| +0.2% | +$18.1K | ﹤0.01% | 2959 |
|
|
2022
Q4 | $10M | Sell |
2,805,638
-2,978
| -0.1% | -$10.7K | ﹤0.01% | 2945 |
|
|
2022
Q3 | $11.3M | Buy |
2,808,616
+50,255
| +2% | +$203K | ﹤0.01% | 2898 |
|
|
2022
Q2 | $12.3M | Buy |
2,758,361
+27,946
| +1% | +$125K | ﹤0.01% | 2877 |
|
|
2022
Q1 | $23.2M | Buy |
2,730,415
+302,362
| +12% | +$2.57M | ﹤0.01% | 2684 |
|
|
2021
Q4 | $21.4M | Buy |
2,428,053
+10,087
| +0.4% | +$89.1K | ﹤0.01% | 2808 |
|
|
2021
Q3 | $25.1M | Buy |
2,417,966
+7,000
| +0.3% | +$72.8K | ﹤0.01% | 2724 |
|
|
2021
Q2 | $25.3M | Buy |
+2,410,966
| New | +$25.3M | ﹤0.01% | 2725 |
|